Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    What does AstraZeneca plc’s deal with Pfizer mean for shareholders?

    | Rupert Hargreaves

    Should you buy, sell or hold AstraZeneca plc (LON: AZN) after the company's Pfizer deal?

    Read more »

    Investing Articles

    3 stocks to help you retire early

    | Peter Stephens

    Retirement planning requires a long-term view and these three shares could bring retirement a big step closer.

    Read more »

    Investing Articles

    Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc?

    | Rupert Hargreaves

    After recent gains is it time to sell GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    These FTSE 100 stars have exploded in Q3! And they’re not finished yet

    | Royston Wild

    Royston Wild considers the share price potential of three FTSE 100 (INDEXFTSE: UKX) fireworks.

    Read more »

    Investing Articles

    Why now is the perfect time to buy these 3 super income stocks

    | Peter Stephens

    These three shares look set to deliver strong returns over the medium-to-long term and the interest rate cut could make…

    Read more »

    Investing Articles

    Are these the FTSE 100’s ‘safest’ dividend stocks?

    | Royston Wild

    Royston Wild reveals four FTSE 100 (INDEXFTSE: UKX) giants with terrific payout prospects.

    Read more »

    Investing Articles

    Tech vs biotech: Is AstraZeneca plc or Apple Inc. the better buy?

    | Prabhat Sakya

    Should you invest in biotech giant AstraZeneca plc (LON:AZN) or consumer king Apple Inc. (NASDAQ:AAPL)?

    Read more »

    Investing Articles

    Should you take a look at these 3 shares after today’s news?

    | Jack Dingwall

    Three great shares to keep an eye on for future investment potential.

    Read more »

    Investing Articles

    3 post-Brexit picks I’d buy now

    | Prabhat Sakya

    Barratt Developments plc (LON:BDEV), Aviva plc (LON:AV) and AstraZeneca plc (LON:AZN) are three candidates for your watch list.

    Read more »

    Investing Articles

    Here’s what Neil Woodford has been buying and selling since the Brexit vote

    | G A Chester

    How has the UK's most renowned investor reacted to the referendum result? Here's what Neil Woodford has been up to.

    Read more »

    Investing Articles

    Will GlaxoSmithKline plc and AstraZeneca plc continue to be Brexit winners?

    | Harvey Jones

    Brexit isn't the only factor driving recent share price growth at GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN),…

    Read more »

    Investing Articles

    3 shares Neil Woodford backs despite Brexit ‘sideshow’

    | Kevin Godbold

    Britain's well-respected fund manager sees bigger problems for Britain than Brexit. This is what he holds to defend against them.

    Read more »